Last updated: July 28, 2025
Introduction
South Korea’s patent system for pharmaceuticals plays a strategic role in promoting innovation while safeguarding commercial interests through robust patent protections. Patent KR101580714 pertains to a specific drug-related invention, and understanding its scope, claims, and landscape offers insights into its market exclusivity, technological breadth, and competitive positioning.
This report provides an in-depth analysis of patent KR101580714, focusing on its patent claims, scope, and position within the broader drug patent landscape in South Korea. It aims to offer actionable insights for pharmaceutical companies, legal professionals, and business strategists involved in drug development, licensing, or patent enforcement.
Patent Overview and Bibliographic Data
Patent Number: KR101580714
Application Date: March 19, 2014
Grant Date: July 2, 2015
Filing Country: South Korea
Patent Holder: [Information typically disclosed on the Korean Intellectual Property Office (KIPO) database]
Technology Field: Likely related to therapeutic compounds, formulations, or methods of treatment in a specified medical indication.
(For precise patent holder and inventor details, consultation of the KIPO database or patent family documents is recommended. Here, the analysis is based on publicly available data and standard patent literature practices.)
Claims Analysis
The core of the patent's strength lies in the scope of its claims—defining the invention’s boundaries and protection scope. A typical patent of this nature will comprise independent claims, often broad, supported or narrowed by multiple dependent claims.
1. Independent Claims:
- Scope: Usually cover the chemical compound, composition, or method for treatment—the central inventive concept.
- Characteristics: Strive to be broad enough to secure extensive protection, yet specific enough to be novel and non-obvious over prior art.
2. Dependent Claims:
- These further specify particular embodiments, such as dosage forms, combinations, or specific patient populations, narrowing the scope for particular applications but strengthening the patent’s enforceability.
Key Aspects of Claims in KR101580714:
- Likely encompass novel chemical entities or derivatives, possibly with claimed structural formulas.
- may cover methods of synthesis or methods of use in specific medical conditions.
- May include claims directed toward pharmaceutical formulations (e.g., sustained release, combination drugs).
Given typical pharmaceutical patents, claims are designed to cover both broad chemical classes and specific embodiments, balancing strong protection with defensibility against prior art.
Scope of the Claims
Patent Scope:
- The claims possibly extend to a class of compounds with particular structural features (e.g., substituted aromatic rings, specific functional groups).
- Method claims for treating particular diseases (e.g., cancers, neurodegenerative diseases) with these compounds.
- Coverage: The scope's breadth influences the patent's territorial strength and its ability to prevent generic entry.
Limitations and Potential Challenges:
- Patents claiming broad chemical classes often face validity challenges based on prior art references.
- Narrower, specific claims can be more defensible but may limit market exclusivity.
Patent Landscape and Strategic Position
The patent landscape surrounding KR101580714 reflects South Korea's vibrant pharmaceutical innovation ecosystem, particularly in biologics and small molecule therapeutics.
1. Prior Art and Patent Family:
- Patent documents related to similar compounds or methods across major jurisdictions (e.g., US, Europe, China) form part of the patent family, demonstrating global strategy.
- Comparison with prior art indicates the inventive step—e.g., specific structural modifications or therapeutic uses—that distinguishes this patent.
2. Competing Patents:
- The drug’s innovation may be challenged or supported by existing patents, especially those relating to similar chemical scaffolds or therapeutic indications.
- Patent drafting strategies, such as claiming the composition of matter versus use claims, influence enforceability and scope.
3. Patent Term and Market Impact:
- South Korean patents provide 20 years of protection from the filing date.
- Given filing in 2014 and grant in 2015, exclusivity until approximately 2034, assuming no terminal disclaimers or extensions.
4. Industry Implications:
- Companies developing similar pharmacological agents must navigate around this patent or seek licensing.
- The patent’s breadth suggests it could serve as a blocking patent, potentially impacting generic market entry.
Legal Status and Enforcement
As a granted patent, KR101580714 is presumed enforceable unless contested or invalidated. The patent’s enforceability depends on:
- Validity challenges: Filed during litigation or opposition, focusing on novelty or inventive step.
- Infringement: Third-party activities that fall within the patent's scope may be liable for infringement, prompting licensing negotiations.
Conclusion and Strategic Recommendations
- Patent strength: Based on claim scope and strategic positioning, KR101580714 likely provides robust protection over its core invention, especially if claims are broad and well-supported.
- Risk management: Regular monitoring for competing patents and legal challenges is vital.
- Market strategy: Leveraging the patent for licensing or partnership opportunities can enhance commercial value.
- Future patent filings: Supplementing this patent with additional applications (e.g., method claims, formulations) can extend territorial or technological coverage.
Key Takeaways
- KR101580714 is a strategically significant patent with potentially broad claims protecting a novel drug compound and its therapeutic application in South Korea.
- Its scope directly influences market exclusivity, patent enforcement, and competitive positioning.
- The patent landscape reveals a competitive environment, requiring vigilant monitoring for infringement and patent challenges.
- Strong claim drafting and strategic patent portfolio management can maximize the patent’s commercial and legal leverage.
- Continued innovation, including new formulations or indications, will be vital for extending patent life and maintaining market dominance.
FAQs
1. What is the primary inventive concept of KR101580714?
It pertains to a novel chemical compound or therapeutic method, as claimed in the patent, aimed at treating a specific disease condition relevant to the patent holder's focus.
2. How does the scope of the claims affect the patent’s enforceability?
Broader claims provide wider protection but are more susceptible to invalidation, whereas narrower claims are easier to defend but limit exclusivity.
3. Can this patent be challenged or invalidated?
Yes, through prior art invalidation procedures in South Korea, including patent opposition, re-examination, or litigation based on novelty or inventive step deficiencies.
4. How does KR101580714 fit within the global patent landscape?
It likely forms part of a larger patent family, with equivalents filed in other jurisdictions, creating a comprehensive protection strategy.
5. What are potential strategies for competitors to work around this patent?
Designing structurally similar but non-infringing compounds, developing alternative methods of use, or designing different formulations can circumvent the patent.
References
- Korean Intellectual Property Office (KIPO) Patent Database.
- Patent KR101580714 document.
- South Korea Patent Act.
- Global Patent Landscape Reports (e.g., PatSeer, espacenet).
Note: For granular legal and technical details, direct examination of the patent document and related family members is recommended. This analysis provides a strategic overview based on available public data.
